Boston Financial & Equity closed a $350,000 lease line with a company that is developing a bench top system to address the acute need in biologic product development and manufacturing.
The system will provide real-time, rapid and direct characterizations of proteins.
The California-based company was founded in 2015. Still in a design & research phase, it has no revenue and is backed by angel investors.
The company currently has eight months of cash, and is in talks with a large drug company to implement a beta system. It’s first drawdown was for a much needed mass spec system.
Like this story? Begin each business day with news you need to know! Click here to register now for our FREE Daily E-News Broadcast and start YOUR day informed!
One Reply to “Boston Financial Provides $350K Lease to Biologic Product Development Co.”
BFEC is great. I have had the opportunity to work with Jim Beauregard from BFEC on a few deals and he is a real pro. I highly suggest utilizing their services.